| Name | Title | Contact Details |
|---|
Ottobock was founded in Germany in 1919 by Otto Bock, a prosthetist. His vision of restoring mobility lives on today, growing to serve the world with more than 46 locations reaching more than 100 countries. The company is headquartered in Duderstadt, Germany, and has more than 5,000 employees. In the early 20th century, Otto Bock transformed the way prosthetic limbs were made. Instead of carving wood to fit a patient, he applied manufacturing techniques and created separate components (like knees and feet) that could be combined, altered or customized to create a limb that was still unique to each patient – but wasn’t built from scratch. Because of his pioneering work, Prosthetists were able to meet the demand generated by World War I and help veterans stay as active as possible. In 1958, our North American headquarters were established in Minneapolis, Minnesota. Our Canadian branch was founded in 1978 and is currently located in Toronto, Ontario. As the first branch, North America has led the way in advocating for and supporting local needs while still tapping into a global network of research and development, manufacturing, and clinical expertise. The people who use our products benefit from the synergy of a worldwide organization complemented by a local connection. Finally, Ottobock continues to give back to the community, supporting various charities and projects that are consistent with our mission of restoring independence.
Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific`s Reveal™ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specific`s unique patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specific`s system streamlines lab workflow, reduce costs, and substantially shorten the time from sample arrival to selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections. Specific and its founders have written almost 60 peer-reviewed publications, detailing the successful demonstration of the SMS array technology. The Company itself has independently authored over 20 scientific publications and conference abstracts detailing the SMS array powered detection, identification and antibiotic susceptibility testing.
first health care group inc is a Bloomington, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Aseptico Inc is a Woodinville, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Laboratory Specialists is a Toledo, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.